These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34395473)

  • 21. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium.
    Falzone L; Salomone S; Libra M
    Front Pharmacol; 2018; 9():1300. PubMed ID: 30483135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging therapeutic agents for advanced non-small cell lung cancer.
    Chen R; Manochakian R; James L; Azzouqa AG; Shi H; Zhang Y; Zhao Y; Zhou K; Lou Y
    J Hematol Oncol; 2020 May; 13(1):58. PubMed ID: 32448366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging drugs for the treatment of cervical cancer.
    Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conceptual Framework for Therapeutic Development Beyond Anti-PD-1/PD-L1 in Urothelial Cancer.
    Grivas P; Drakaki A; Friedlander TW; Sonpavde G
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():284-300. PubMed ID: 31099684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
    BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plants and cervical cancer: an overview.
    Wang SJ; Zheng CJ; Peng C; Zhang H; Jiang YP; Han T; Qin LP
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1133-56. PubMed ID: 23789984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
    Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
    Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer.
    Bearz A; Cecco S; Francescon S; Re FL; Corona G; Baldo P
    Recent Pat Anticancer Drug Discov; 2019; 14(3):242-257. PubMed ID: 31362665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility.
    Bózsity N; Minorics R; Szabó J; Mernyák E; Schneider G; Wölfling J; Wang HC; Wu CC; Ocsovszki I; Zupkó I
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):247-257. PubMed ID: 27363663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
    Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW
    Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
    Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
    Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib targets the caspase-like proteasome activity in cervical cancer cells, triggering apoptosis that can be enhanced by nelfinavir.
    Bruning A; Vogel M; Mylonas I; Friese K; Burges A
    Curr Cancer Drug Targets; 2011 Sep; 11(7):799-809. PubMed ID: 21762082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives.
    Wang Y; Li G
    Front Med; 2019 Aug; 13(4):438-450. PubMed ID: 30826965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.